Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on wearable injectors market provides in-depth analysis of segments and sub-segments in global as well as regional wearable injectors market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional wearable injectors market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global wearable injectors market. According to the report the global wearable injectors market is projected to grow at a CAGR of 13.4% over the forecast period of 2018-2024.
Wearable Injectors or patch pumps or patch injector are drug delivery devices, designed specifically for patients, for self-administration of large volume drugs. It used for the subcutaneous injection of insulin and other drugs delivery which infuses, 2-10ml of the drug, within 2-15 minutes. A large number of new biologic require high doses and viscous formulation that cannot be injected by using a syringe or another legacy system hence they delivered intravenously or novel drug delivery technology that is eco-friendly, safe and cost-effective. Improved quality of life of patients with self-administered wearable injector used in the home environment. Wearable injector technology platform enables cost-effective, easy, reliable, comfortable and flexible drug delivery.
Wearable injectors are convenient and cost-effective self-administration platform for large and viscous doses. High prevalence of chronic diseases, cardiovascular disease, blood disorders, and infectious disease requires large and viscous doses which in turn, is driving the demand for the wearable injectors market. Moreover, growing awareness related to the need stick injuries and rising in the population are also the factors, augmenting the market growth of the wearable injectors market. In addition, rising demand for warble injectors is the largest driver for the pharmaceutical and biotechnology market.
Moreover, technological advancement such as sending alerts to patients like injection reminders to make self-injection safe, easy, comfortable and convenient for the user. In addition, patients can self-administer drugs subcutaneously in less time and home care services are some supporting factors which drive the growth of the market. Going further, the necessity for better patient care do not require patient training is anticipated to offer growth opportunities for the wearable injectors market.
Among the regions, North America is projected to be the dominant region in the wearable injectors market. High prevalences and occurrences of chronic diseases and huge expenditure on the healthcare sectors and on-going innovations in the wearable injectors are some of the factors boosting the market in the North America region. The Asia-Pacific region is estimated to be the fastest growing region as compared to other region owing to the rising geriatric population coupled with incidences of chronic diseases and increasing awareness about the medical device such as wearable injector. The countries such as China and India are boosting the wearable injectors market in the Asia-Pacific region over the forecast period.
The report on global wearable injectors market covers segments such as type, application, and end user industry. On the basis of type, the global wearable injectors market is categorized into a body worn patch injectors and off body worn patch injectors. On the basis of application, the global wearable injectors market is categorized into oncology, infectious disease, cardiovascular disease, autoimmune disease, and diabetes. On the basis of end user industry, the global wearable injectors market is categorized into retail pharmacies, online pharmacies, specialty clinics, hospitals, clinics, home care settings, and others.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-Pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global wearable injectors market such as Becton, SteadyMed Therapeutics, Inc, Sensile Medical AG, Debiotech S.A., CeQur SA., West Pharmaceutical Services, Inc., Ypsomed AG, Insulet Corporation, Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche Ltd.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global wearable injectors market. Moreover, IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of wearable injectors market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the wearable injectors market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the wearable injectors market to understand the present and future trends in this market and formulate their strategies accordingly.
Please Choose One of them.